Overview

FDA-approved procedure performed on women worldwide since 1994 and clinically proven to be successful in reducing the major symptoms of uterine fibroids.

Uterine fibroids are benign, noncancerous growths within or on the muscular walls of the uterus. The size of the fibroids can range in size from ¼-inch to the size of a cantaloupe. Uterine fibroids are relatively common and affect 20 percent to 40 percent of women of child-bearing age. African-American women are the most racially prone group, as are women with a family history of fibroids.

Uterine fibroid embolization is an alternative to the surgical removal of the fibroids (myomectomy) or removal of the entire uterus (hysterectomy). Led by Uma Prasad, M.D., physicians at VCU Uterine Fibroid Embolization (UFE) offer women this alternative treatment option to surgery.

During the minimally invasive procedure, interventional radiologists use X-ray imaging to guide a catheter to the uterine arteries. Tiny particles are then injected through the catheter into the blood vessels, blocking the blood supply feeding the fibroids, which causes them to shrink and die. 

Patients typically notice a 50 percent reduction in the size of the fibroids within three to six months and an 80 percent reduction after the first year. Overall, patients experience a 90 percent improvement of symptoms.

Patients and referring physicians visit Uterine Fibroid Embolization at VCU Health.